COMP <GO>
ANF vs PG // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Abercrombie & Fitch Company (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: ANF 8
— PG 5
■ METRIC PARITY
LAST: $164.44 (-0.80%) • MKT CAP: $7.03B
options-implied-move
6.50%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
options-implied-move
6.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANF VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ANF | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 40.70% | 25.40% | +15.30 | ANF | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.7x | 16.2x | -8.50 | ANF | /valuation <GO> |
| Free Cash Flow Yield | 5.38% | 3.77% | +1.61 | ANF | /fcf-yield <GO> |
| Operating Margin | 13.30% | 24.30% | -11.00 | PG | /operating-margins <GO> |
| Net Profit Margin | 9.60% | 19.00% | -9.40 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | 0.30% | +6.10 | ANF | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.27 | 5.59 | +0.68 | ANF | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ANF | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.50% | 6.50% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.2 | 62.7 | +2.52 | ANF | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.87 | 0.87 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.9x | 21.7x | -8.80 | ANF | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.03B | $372.21B | -$365.18B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ANF REV | PG REV | ANF GROSS % | PG GROSS % | ANF FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.27B | $84.28B | 44.0% | 51.2% | $378.4M | $14.04B |
| FY 2024 | $4.95B | $84.04B | 44.0% | 51.4% | $527.5M | $16.52B |
| FY 2023 | $4.28B | $82.01B | 44.0% | 44.0% | $460.8M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANF // BETA 0.87
PG // BETA 0.87